Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 5, 2011, Pages 1168-1178

  Gill, Jagbir ^a   Sampaio, Marcelo ^b   Gill, John S ^a   Dong, James ^a   Kuo, Hung Tien ^c,d   Danovitch, Gabriel M ^d   Bunnapradist, Suphamai ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; CYCLOSPORIN; EVEROLIMUS; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ELDERLY CARE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RISK ASSESSMENT; UNITED STATES;

ACUTE DISEASE; ADULT; AGE DISTRIBUTION; AGED; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTILYMPHOCYTE SERUM; ANTINEOPLASTIC AGENTS; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RABBITS; RISK FACTORS; TISSUE DONORS; UNITED STATES;

EID: 79957843431     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07540810     Document Type: Article

References (26)

1. Cohen DJ, St Martin L, Christensen LL, Bloom RD, Sung RS: Kidney and pancreas transplantation in the United States, 1995-2004. Am J Transplant 5: 1153-1169, 2006
2. Danovitch GM, Cohen DJ, Weir MR, Stock PG, Bennett WM, Christensen LL, Sung RS: Current status of kidney and pancreas transplantation in the United States, 1994-2003. Am J Transplant 4: 904-915, 2005
3. Danovitch GM, Gill J, Bunnapradist S: Immunosuppression of the elderly kidney transplant recipient. Transplantation 3: 285-291, 2007
4. Meier-Kriesche HU, Ojo A, Hanson J, Cibrik D, Lake K, Agodoa LY, Leichtman A, Kaplan B: Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation 5: 885-889, 2000
5. Meier-Kriesche HU, Ojo AO, Hanson JA, Kaplan B: Exponentially increased risk of infectious death in older renal transplant recipients. Kidney Int 4: 1539-1543, 2001
6. Trouillhet I, Benito N, Cervera C, Rivas P, Cofan F, Almela M, Angeles Marcos M, Puig de la Bellacasa J, Pumarola T, Oppenheimer F, Moreno-Camacho A: Influence of age in renal transplant infections: Cases and controls study. Transplantation 7: 989-992, 2005
7. Martins PN, Pratschke J, Pascher A, Fritsche L, Frei U, Neuhaus P, Tullius SG: Age and immune response in organ transplantation. Transplantation 2: 127-132, 2005
8. Cecka JM: The OPTN/UNOS renal transplant registry. Clin Transpl 1-16, 2004
9. Schold JD, Meier-Kriesche HU: Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis? Clin J Am Soc Nephrol 3: 532-538, 2006
10. Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D: Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 19: 1967-1977, 2006
11. Cardinal H, Hebert MJ, Rahme E, Houde I, Baran D, Masse M, Boucher A, Le Lorier J; Elderly Recipients Transplant Group: Modifiable factors predicting patient survival in elderly kidney transplant recipients. Kidney Int 1: 345-351, 2005
12. Frei U, Noeldeke J, Machold-Fabrizii V, Arbogast H, Margreiter R, Fricke L, Voiculescu A, Kliem V, Ebel H, Albert U, Lopau K, Schnuelle P, Nonnast-Daniel B, Pietruck F, Offerman R, Persijn G, Bernasconi C: Prospective age-matching in elderly kidney transplant recipients-A 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 1: 50-57, 2008
13. Heldal K, Hartmann A, Leivestad T, Svendsen MV, Foss A, Lien B, Midtvedt K: Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity. Transplantation 7: 1045-1051, 2009
14. Gill JS, Gill J, Rose C, Zalunardo N, Landsberg D: The older living kidney donor: Part of the solution to the organ shortage. Transplantation 12: 1662-1666, 2006
15. Merion RM, Ashby VB, Wolfe RA, Distant DA, Hulbert- Shearon TE, Metzger RA, Ojo AO, Port FK: Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 21: 2726-2733, 2005
16. Noel C, Abramowicz D, Durand D, Mourad G, Lang P, Kessler M, Charpentier B, Touchard G, Berthoux F, Merville P, Ouali N, Squiffelet JP, Bayle F, Wissing KM, Hazzan M: Daclizumab versus antithymocyte globulin in high-immunological- risk renal transplant recipients. J Am Soc Nephrol 6: 1385-1392, 2009
17. Yarlagadda SG, Coca SG, Formica RN Jr, Poggio ED, Parikh CR: Association between delayed graft function and allograft and patient survival: A systematic review and meta-analysis. Nephrol Dial Transplant 3: 1039-1047, 2009
18. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK: Long-term survival in renal transplant recipients with graft function. Kidney Int 1: 307-313, 2000
19. Heaf JG, Ladefoged J: The effect of acute rejection on longterm renal graft survival is mainly related to initial renal damage. Transpl Int S26-S31, 1998
20. Meier-Kriesche HU, Srinivas TR, Kaplan B: Interaction between acute rejection and recipient age on long-term renal allograft survival. Transplant Proc 33: 3425-3426, 2001
21. Schold JD, Kaplan B, Chumbler NR, Howard RJ, Srinivas TR, Ma L, Meier-Kriesche HU: Access to quality: Evaluation of the allocation of deceased donor kidneys for transplantation. J Am Soc Nephrol 10: 3121-3127, 2005
22. Sung RS, Guidinger MK, Lake CD, McBride MA, Greenstein SM, Delmonico FL, Port FK, Merion RM, Leichtman AB: Impact of the expanded criteria donor allocation system on the use of expanded criteria donor kidneys. Transplantation 9: 1257-1261, 2005
23. Huang E, Cho YW, Hayashi R, Bunnapradist S: Alemtuzumab induction in deceased donor kidney transplantation. Transplantation 7: 821-828, 2007
24. Huang E, Cho YW, Shah T, Peng A, Hayashi R, Bunnapradist S: Alemtuzumab induction in kidney transplantation. Clin Transpl 343-354, 2005
25. Sampaio MS, Kadiyala A, Gill J, Bunnapradist S: Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor kidney transplantation. Transplantation 7: 904-910, 2009
26. Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ: A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Transplantation 6:810- 819, 2009